SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-22-000056
Filing Date
2022-11-03
Accepted
2022-11-03 09:26:07
Documents
14
Period of Report
2022-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20221103x8k.htm   iXBRL 8-K 82082
2 EX-99.1 sava-20221103xex99_1.htm EX-99.1 31973
3 GRAPHIC sava-20221103xex99_1g001.jpg GRAPHIC 42544
  Complete submission text file 0001069530-22-000056.txt   299105

Data Files

Seq Description Document Type Size
4 EX-101.SCH sava-20221103.xsd EX-101.SCH 2656
5 EX-101.LAB sava-20221103_lab.xml EX-101.LAB 15224
6 EX-101.PRE sava-20221103_pre.xml EX-101.PRE 10841
8 EXTRACTED XBRL INSTANCE DOCUMENT sava-20221103x8k_htm.xml XML 4827
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 221356519
SIC: 2834 Pharmaceutical Preparations